Paul M. Mendelman

8.0k total citations · 1 hit paper
97 papers, 6.0k citations indexed

About

Paul M. Mendelman is a scholar working on Epidemiology, Infectious Diseases and Microbiology. According to data from OpenAlex, Paul M. Mendelman has authored 97 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Epidemiology, 30 papers in Infectious Diseases and 30 papers in Microbiology. Recurrent topics in Paul M. Mendelman's work include Respiratory viral infections research (32 papers), Pneumonia and Respiratory Infections (30 papers) and Bacterial Infections and Vaccines (29 papers). Paul M. Mendelman is often cited by papers focused on Respiratory viral infections research (32 papers), Pneumonia and Respiratory Infections (30 papers) and Bacterial Infections and Vaccines (29 papers). Paul M. Mendelman collaborates with scholars based in United States, Switzerland and Japan. Paul M. Mendelman's co-authors include Robert B. Belshe, David I. Bernstein, Mark Wolff, John J. Treanor, Arnold L. Smith, William C. Gruber, Ken Zangwill, Karen Kotloff, Pedro A. Piedra and James C. King and has published in prestigious journals such as New England Journal of Medicine, The Lancet and PEDIATRICS.

In The Last Decade

Paul M. Mendelman

97 papers receiving 5.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Efficacy of Live Attenuated, Cold-Adapted, Trivalent, Intranasal Influenzavirus Vaccine in Children

1998 697 citations Robert B. Belshe, Paul M. Mendelman et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul M. Mendelman United States	40	3.8k	2.2k	1.1k	737	670	97	6.0k
C. A. Hart United Kingdom	44	2.0k 0.5×	2.1k 1.0×	647 0.6×	615 0.8×	362 0.5×	207	6.3k
Michael D. Nissen Australia	52	4.1k 1.1×	2.9k 1.3×	1.3k 1.2×	370 0.5×	905 1.4×	172	7.7k
Theo P. Sloots Australia	50	3.8k 1.0×	2.6k 1.1×	1.1k 1.1×	327 0.4×	759 1.1×	194	7.5k
Eric C. J. Claas Netherlands	51	6.2k 1.6×	4.0k 1.8×	516 0.5×	690 0.9×	495 0.7×	182	9.0k
Anna Giammanco Italy	40	2.1k 0.6×	2.9k 1.3×	1.3k 1.2×	261 0.4×	850 1.3×	306	6.5k
Kate Templeton United Kingdom	45	3.9k 1.0×	3.7k 1.7×	633 0.6×	270 0.4×	1.1k 1.6×	179	7.2k
Genevieve A. Losonsky United States	48	1.9k 0.5×	3.2k 1.4×	383 0.4×	1.2k 1.6×	352 0.5×	97	7.0k
Bruno Pozzetto France	43	2.2k 0.6×	2.1k 0.9×	424 0.4×	889 1.2×	768 1.1×	297	6.4k
Olli Meurman Finland	37	2.5k 0.7×	1.1k 0.5×	712 0.7×	382 0.5×	317 0.5×	115	4.3k
Eun Hwa Choi South Korea	36	2.9k 0.8×	1.7k 0.7×	839 0.8×	244 0.3×	169 0.3×	246	4.8k

Countries citing papers authored by Paul M. Mendelman

Since Specialization

Citations

This map shows the geographic impact of Paul M. Mendelman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul M. Mendelman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul M. Mendelman more than expected).

Fields of papers citing papers by Paul M. Mendelman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul M. Mendelman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul M. Mendelman. The network helps show where Paul M. Mendelman may publish in the future.

Co-authorship network of co-authors of Paul M. Mendelman

This figure shows the co-authorship network connecting the top 25 collaborators of Paul M. Mendelman. A scholar is included among the top collaborators of Paul M. Mendelman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul M. Mendelman. Paul M. Mendelman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sáez‐Llorens, Xavier, Rodrigo DeAntonio, Eduardo López-Medina, et al.. (2025). Safety and immunogenicity of a bivalent norovirus vaccine candidate in infants from 6 weeks to 5 months of age: A phase 2, randomized, double-blind trial. Human Vaccines & Immunotherapeutics. 21(1). 2450878–2450878. 2 indexed citations

Leroux‐Roels, Geert, Jakob P. Cramer, Paul M. Mendelman, et al.. (2017). Safety and Immunogenicity of Different Formulations of Norovirus Vaccine Candidate in Healthy Adults: A Randomized, Controlled, Double-Blind Clinical Trial. The Journal of Infectious Diseases. 217(4). 597–607. 57 indexed citations

Atmar, Robert L., Frank Baehner, Jakob P. Cramer, et al.. (2016). Rapid Responses to 2 Virus-Like Particle Norovirus Vaccine Candidate Formulations in Healthy Adults: A Randomized Controlled Trial. The Journal of Infectious Diseases. 214(6). 845–853. 50 indexed citations

Bergen, Randy, Steve Black, Henry R. Shinefield, et al.. (2004). Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents. The Pediatric Infectious Disease Journal. 23(2). 138–144. 112 indexed citations

Belshe, Robert B., Kristin L. Nichol, Henry R. Shinefield, et al.. (2004). Safety, Efficacy, and Effectiveness of Live, Attenuated, Cold‐Adapted Influenza Vaccine in an Indicated Population Aged 5–49 Years. Clinical Infectious Diseases. 39(7). 920–927. 78 indexed citations

Belshe, Robert B., et al.. (2004). Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine. Expert Review of Vaccines. 3(6). 643–654. 111 indexed citations

Mahmood, Kutubuddin, Lopa Adhikary, Marilyn J. August, et al.. (2004). Measuring Antibody Responses to a Live Attenuated Influenza Vaccine in Children. The Pediatric Infectious Disease Journal. 23(9). 852–856. 43 indexed citations

Belshe, Robert B. & Paul M. Mendelman. (2003). Safety and efficacy of live attenuated, cold-adapted, influenza vaccine-trivalent. Immunology and Allergy Clinics of North America. 23(4). 745–767. 17 indexed citations

Watkins, Sandra L., Steven R. Alexander, Eileen D. Brewer, et al.. (2002). Response to recombinant hepatitis B vaccine in children and adolescents with chronic renal failure. American Journal of Kidney Diseases. 40(2). 365–372. 38 indexed citations

10.

Mendelman, Paul M., et al.. (2001). Half‐Life of Human Parainfluenza Virus Type 3 (hPIV3) Maternal Antibody and Cumulative Proportion of hPIV3 Infection in Young Infants. The Journal of Infectious Diseases. 183(8). 1281–1284. 18 indexed citations

11.

Belshe, Robert B., William C. Gruber, Paul M. Mendelman, et al.. (2000). Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. The Journal of Pediatrics. 136(2). 168–175. 340 indexed citations

12.

Belshe, Robert B., Paul M. Mendelman, John J. Treanor, et al.. (1998). The Efficacy of Live Attenuated, Cold-Adapted, Trivalent, Intranasal Influenzavirus Vaccine in Children. New England Journal of Medicine. 338(20). 1405–1412. 697 indexed citations breakdown →

13.

Mendelman, Paul M., Steven Bird, Holly Matthews, et al.. (1997). Immunogenicity and safety of Haemophilus influenzae type b polysaccharide-Neisseria meningitidis conjugate vaccine in 7.5 μg liquid formulation: a comparison of three lots with the 15.0 μg lyophilized formulation. Vaccine. 15(6-7). 775–781. 6 indexed citations

14.

Kostman, Jay R., Bettylou Sherry, Corinne L. Fligner, et al.. (1993). Invasive Haemophilus influenzae Infections in Older Children and Adults in Seattle. Clinical Infectious Diseases. 17(3). 389–396. 15 indexed citations

15.

Mendelman, Paul M., et al.. (1990). Cefuroxime Treatment Failure of Nontypable Haemophilus influenme Meningitis Associated with Alteration of Penicillin-Binding Proteins. The Journal of Infectious Diseases. 162(5). 1118–1123. 26 indexed citations

16.

Mendelman, Paul M., et al.. (1989). Lack of toxicity in two cases of neonatal acyclovir overdose. The Pediatric Infectious Disease Journal. 8(8). 529–532. 7 indexed citations

17.

Mendelman, Paul M., et al.. (1988). The penicillin binding proteins of the genus Haemophilus. Journal of Medical Microbiology. 27(2). 95–98. 2 indexed citations

18.

Lévy, J, et al.. (1986). Effect of tobramycin on protein synthesis in 2-deoxystreptamine aminoglycoside-resistant clinical isolates of Haemophilus influenzae. Antimicrobial Agents and Chemotherapy. 29(3). 474–481. 14 indexed citations

19.

Mendelman, Paul M. & Donald O. Chaffin. (1985). Two penicillin binding proteins ofHaemophilus influenzaeare lost after cells enter stationary phase. FEMS Microbiology Letters. 30(3). 399–402. 15 indexed citations

20.

Mendelman, Paul M., Marilyn C. Roberts, & Arnold L. Smith. (1982). Mutation frequency of Haemophilus influenzae to rifampin resistance. Antimicrobial Agents and Chemotherapy. 22(3). 531–533. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact